GeoVax Labs, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 0.1859 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.69M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; and the U.S. Department of Defense. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.
Details
| Name | GeoVax Labs, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 19 |
| Founded | 2001 |
| Ceo | David Dodd |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US3736787058 |
| Cusip | 373678705 |
| Cik | 0000832489 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Valerie C. Montgomery Rice FACOG, M.D. | Special Advisor to the Chairman and Chief Executive Officer and Director |
| David Alan Dodd | Chairman, President and Chief Executive Officer |
| Dr. Mark J. Newman Ph.D. | Chief Scientific Officer |
| Dr. Kelly T. McKee Jr., M.D., M.P.H. | Chief Medical Officer |
| Mark W. Reynolds CPA | Chief Financial Officer and Corporate Secretary |
| Thomas O'Brien | Vice President of Quality Systems and Compliance |
| Jeffrey Welch | Head of Process Development and Manufacturing Operations |
| Dr. John W. Sharkey Ph.D. | Vice President of Business Development |
Contact
| Address | 1955 Lake Park Drive, Suite 380, Smyrna, Georgia 30080, United States |
| Phone | 678 384 7220 |
| Website | https://www.geovax.com |